Overview
Louis Volino is a primary care provider, practicing in Internal Medicine in Youngstown, Ohio. Dr. Volino is rated as an Advanced provider by MediFind in the treatment of Necrotizing Fasciitis. His top areas of expertise are Necrosis, Acute Kidney Failure, Lung Metastases, Gastrostomy, and Endoscopy. Dr. Volino is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- HMO
- PPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
7630 Southern Blvd, Youngstown, OH 44512
7629 Market St, Youngstown, OH 44512
Triad Health Services LLC
Vivian Starr is a primary care provider, practicing in Internal Medicine in Youngstown, Ohio. Dr. Starr is rated as an Advanced provider by MediFind in the treatment of Necrotizing Fasciitis. Her top areas of expertise are Malnutrition, Hospital-Acquired Pneumonia, Atypical Pneumonia, Gastrostomy, and Endoscopy. Dr. Starr is currently accepting new patients.
Triad Health Services LLC
Santuccio Ricciardi is a primary care provider, practicing in Internal Medicine in Youngstown, Ohio. Dr. Ricciardi is rated as a Distinguished provider by MediFind in the treatment of Necrotizing Fasciitis. His top areas of expertise are High Cholesterol, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Gastrostomy, and Vertebroplasty. Dr. Ricciardi is currently accepting new patients.
Thomas Mandat is a primary care provider, practicing in Internal Medicine in Parma, Ohio. Dr. Mandat is rated as a Distinguished provider by MediFind in the treatment of Necrotizing Fasciitis. His top areas of expertise are Necrosis, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Gastrostomy, and Endoscopy. Dr. Mandat is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Kidney FailureDr. Volino isDistinguished. Learn about Acute Kidney Failure.
- NecrosisDr. Volino isDistinguished. Learn about Necrosis.
- Advanced
- Acute PancreatitisDr. Volino isAdvanced. Learn about Acute Pancreatitis.
- AnemiaDr. Volino isAdvanced. Learn about Anemia.
- ApoplexyDr. Volino isAdvanced. Learn about Apoplexy.
- Atypical PneumoniaDr. Volino isAdvanced. Learn about Atypical Pneumonia.
- Bacterial GastroenteritisDr. Volino isAdvanced. Learn about Bacterial Gastroenteritis.
- CellulitisDr. Volino isAdvanced. Learn about Cellulitis.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Volino isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute CystitisDr. Volino isExperienced. Learn about Acute Cystitis.
- Acute Interstitial PneumoniaDr. Volino isExperienced. Learn about Acute Interstitial Pneumonia.
- Acute Tubular NecrosisDr. Volino isExperienced. Learn about Acute Tubular Necrosis.
- Alcoholic CirrhosisDr. Volino isExperienced. Learn about Alcoholic Cirrhosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Volino isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.